Skip to content
THE LIBERTY TRIBUNE

Amid Review Of Deadly Abortion Drug, FDA Greenlights Copycat

By The Liberty Tribune Staff · Published: · Updated: · 1 min read

abortion FDA mifepristone health politics
Amid Review Of Deadly Abortion Drug, FDA Greenlights Copycat — Explainer

What it is

The U.S. Food and Drug Administration (FDA) has approved a generic version of mifepristone, a medication widely used for abortions, manufactured by Evita Solutions. This decision comes after the agency announced plans to re-evaluate the safety and efficacy of mifepristone amid ongoing scrutiny.

Why it matters

  • In a letter to 22 Republican attorneys general on September 19, Kennedy and FDA Commissioner Marty Makary reiterated that the agency would conduct its own review of evidence related to mifepristone's safety and efficacy
  • Both the Danco and Evita products will carry the same labeling, in accordance with FDA policy for generics
  • Anthony Pro-Life America criticized the FDA's decision, stating that it expands access to drugs that they argue endanger unborn children and women's health
  • The Supreme Court has previously declined to rule on the legality of mifepristone's approval, leaving the door open for future challenges

Key facts

  • Food and Drug Administration FDA has approved a generic version of mifepristone, a medication widely used for abortions, manufactured by Evita Solutions
  • This decision comes after the agency announced plans to re evaluate the safety and efficacy of mifepristone amid ongoing scrutiny

Primary sources

Further reading & references

Related explainers